ARTICLE | Clinical News
Sancuso granisetron patch regulatory update
April 30, 2012 7:00 AM UTC
The European Commission approved an MAA from Kyowa's ProStrakan Group plc subsidiary for Sancuso granisetron to prevent nausea and vomiting associated with moderately or highly emetogenic chemotherap...